Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 21 Show results per page	View Search Criteria \| Help With Results

Last Modified: 12/2/2008 First Published: 5/1/2007


1.		Phase I/II Study of Calcitriol, Cisplatin, and Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Treatment				Temporarily closed				Over 18				NCI				RPCI-I-83706 NCT00470431, I 83706

Last Modified: 12/2/2008 First Published: 9/26/2007


2.		Phase I/II Study of Calcitriol, Ketoconazole, and Hydrocortisone in Patients With Advanced or Recurrent Androgen-Independent Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				NCI				RPCI-I-68905 I 68905, NCT00536991

Last Modified: 1/1/1998 First Published: 11/1/1997


3.		Phase II Chemoprevention Study of Vitamin D3 and Calcium for Colorectal Cancer (Summary Last Modified 01/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Closed				Over 18				NCI				CPMC-IRB-6850 NCI-P97-0109

Last Modified: 11/1/2000 First Published: 11/1/1999


4.		Phase II Study of Pulse Calcitriol in Patients With Rising PSA After Treatment for Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Other				OHSU-5231 OCC-HOR-98068-L, NCI-V99-1542, NCT00004043

Last Modified: 6/1/2002 First Published: 6/1/2001


5.		Phase II Study of Calcitriol and Carboplatin in Patients With Androgen-Independent Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				OHSU-6218 OHSU-HOR-00059-L, NCI-G01-1963, NCT00017576

Last Modified: 10/1/1993


6.		Phase II Study of Calcitriol in Patients with Hormone-Resistant Prostate Cancer (Summary Last Modified 10/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								PCI-9304 NCI-V93-0286

Last Modified: 2/9/2005 First Published: 1/26/2003


7.		Phase II Study of Calcitriol and Dexamethasone in Patients With Early, Recurrent Prostate Cancer After Prior Radical Prostatectomy or Radiotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				RPCI-RP-0203 PCI-00-034, NCT00054522

Last Modified: 8/12/2008 First Published: 6/25/2005


8.		Phase II Randomized Chemoprevention Study of Calcitriol in Patients With High-Grade Prostatic Intraepithelial Neoplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Closed				18 and over				NCI				CINJ-080404 NJ 3803, CINJ-4901, CINJ-NJ3803, CINJ-5111, NCT00118066

Last Modified: 10/16/2007 First Published: 9/9/2005


9.		Phase II Study of High-Dose Pulse Calcitriol, Mitoxantrone, and Prednisone in Patients With Androgen-Independent Metastatic Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 100				NCI				OHSU-8451 OHSU-VA-IRB-9451, NCT00182741

Last Modified: 12/20/2007 First Published: 10/7/2005


10.		Phase II Study of Calcitriol and Docetaxel in Patients With Metastatic or Locally Advanced Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				Over 18				NCI				OHSU-GIM-02007-L OHSU-1104, NCT00238199

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute